A Single-Arm, Open-Label, Exploratory Mechanistic Validation (PoM) Clinical Trial of Toludesvenlafaxine Hydrochloride Extended-Release Tablets Assessing Dopamine Transporter Occupancy in the Patients With Depression Brain Using 11C-CFT Positron Emission Tomography (PET)
Latest Information Update: 24 Oct 2023
At a glance
- Drugs Toludesvenlafaxine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
Most Recent Events
- 18 Oct 2023 Status changed from not yet recruiting to recruiting.
- 13 Sep 2023 New trial record